MAPT and Alzheimer disease: Aberrant production of p-tau in the central nervous system is linked to neurodegenerative diseases such as Alzheimer Disease dementia, Parkinson’s disease, traumatic brain injury, epilepsy or stroke, all of them associated to aging and neurodegeneration (Zheng et al., 2014).